Eton Pharmaceuticals (ETON) Current Assets (2017 - 2025)

Eton Pharmaceuticals has disclosed Current Assets across 9 years of filings, most recently posting $60.6 million for Q4 2025.

• Current Assets for Q4 2025 came in at $60.6 million, up 47.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $60.6 million (up 47.68% YoY), and the FY2025 annual result was $60.6 million, up 47.68% from the prior year.
• Current Assets came in at $60.6 million for Q4 2025 at Eton Pharmaceuticals, down from $72.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $72.0 million in Q3 2025 to a low of $16.4 million in Q3 2022.
• The 5-year median for Current Assets is $26.6 million (2023), against an average of $32.7 million.
• Across the five-year window, Current Assets plunged 38.06% in 2022 and soared 169.1% in 2025, its largest moves.
• Eton Pharmaceuticals' Current Assets stood at $23.6 million in 2021, then declined by 15.25% to $20.0 million in 2022, then jumped by 34.17% to $26.8 million in 2023, then jumped by 52.84% to $41.0 million in 2024, then soared by 47.68% to $60.6 million in 2025.
• The last three Current Assets figures came in at $60.6 million (Q4 2025), $72.0 million (Q3 2025), and $68.4 million (Q2 2025), per Business Quant data.